Finance
GSK licenses liver disease drug to Italy's Alfasigma for up to $690 million
March 9 (Reuters) - GSK said on Monday it will receive up to $690 million from Italian pharmaceutica...
9th March, 2026
Pharmaceuticals
Finance
Galderma gives better than expected 2026 guidance, shares rise
March 5 (Reuters) - Shares of Swiss skincare company Galderma opened higher on Thursday after it rep...
5th March, 2026
Finance
Sino Biopharm unit licenses blood cancer drug to Sanofi for up to $1.53 billion
March 4 (Reuters) - Hong Kong-listed Sino Biopharmaceutical said on Wednesday its unit has signed an...
3rd March, 2026
Finance
Hims' pharmacy partner will reintroduce GLP-1 pill pulled from market, Endpoints News reports
March 3 (Reuters) - Hims & Hers Health's pharmacy partner, Strive Pharmacy, plans to resume sales of...
3rd March, 2026
Finance
Roche targets double-digit market share in weight loss, aims to catch up with Novo Nordisk, Handelsblatt reports
BERLIN, March 3 (Reuters) - Swiss pharmaceutical company Roche is aiming for a double-digit market s...
3rd March, 2026
Finance
EU regulator backs approval for Moderna's combined COVID and flu vaccine
By Bhanvi Satija Feb 27 (Reuters) - Europe's medicines regulator recommended approval for Moderna's...
27th February, 2026
Finance
Drugmaker Rovi's net profit rises on higher Okedi, heparin sales
Feb 25 (Reuters) - Spanish drugmaker Laboratorios Farmaceuticos Rovi said on Wednesday its 2025 net...
25th February, 2026
Investing
US, GERMAN DRUGMAKERS TEAM UP ON CANCER MEDICINES
The Associated Press NEW YORK (AP) — Pfizer says it will partner with German drug and chemical maker...
18th November, 2014
Top Stories
GSK’s PLANNED DIVESTMENT
GlaxoSmithKline has not experienced the best of years, facing a difficult environment for sales, fac...
13th November, 2014
Top Stories
TXCELL ACHIEVES POSITIVE RESULTS FOR COL-TREG IN A MODEL OF AUTOIMMUNE UVEITIS
TxCell set for phase I/II proof of principle clinical study in Q2 2015 for its second therapeutic ca...
1st November, 2014
Top Stories
MORRISON & FOERSTER WINS 10TH CIRCUIT DISMISSAL OF SECURITIES CLASS ACTION AGAINST MEDICAL DEVICE COMPANY
AspenBio Pharma had been accused of misleading investors over prospects for appendicitis test; MoFo...
29th October, 2014
Interviews
M&A ACTIVITY
Wanda Rich, editor of Global Banking & Finance Review interviewed Lance Walter, CMO of Host Anal...
18th October, 2014